Vanguard Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1M Buy
3,830,455
+46,068
+1% +$160K ﹤0.01% 2750
2026
Q2
$12.9M Buy
3,784,387
+8,651
+0.2% +$28.8K ﹤0.01% 2684
2026
Q1
$13.5M Buy
+3,775,736
New +$15M ﹤0.01% 2564

Other funds holding RCKT

Vanguard Capital Management's RCKT Position: Q3 2026 in Review

Vanguard Capital Management increased its Rocket Pharmaceuticals (RCKT) stake by 1.2% in Q3 2026, buying an estimated $160K and bringing the position to 3,830,455 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

Vanguard Capital Management first reported a position in RCKT in Q1 2026 and has held it in 3 quarters since. The position peaked at $13.5M in Q1 2026. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • Vanguard Capital Management held 3,830,455 shares of Rocket Pharmaceuticals worth $10.1M as of Q3 2026.
  • Vanguard Capital Management bought 46,068 Rocket Pharmaceuticals shares in Q3 2026, an estimated $160K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2750 holding.
  • Vanguard Capital Management first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Rocket Pharmaceuticals position peaked at $13.5M in Q1 2026.
  • 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.